Hakeem Health develops HakeemDx, a platform that integrates with hospital EMR and laboratory systems to deliver real-time, evidence-based clinical guidance in Arabic and English at the point of care. The bilingual capability is a deliberate design choice to serve GCC health systems rather than adapting products built elsewhere. The company targets clinicians working in over 2,000 hospitals across Saudi Arabia, the UAE, and Egypt who face time-pressured, high-stakes decisions and inconsistent access to up-to-date clinical evidence. Hakeem Health's recent $1.65 million funding round, led by Merak Capital with participation from Sanabil Investments, is intended to accelerate institutional adoption across hospitals and health systems in the region. The raise reflects a regional shift toward investing in clinical infrastructure inside hospitals rather than only patient-facing digital health solutions.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026